Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) FCF Margin (2021)

Atea Pharmaceuticals has reported FCF Margin over the past 1 years, most recently at 39.25% for Q4 2021.

  • Quarterly results put FCF Margin at 39.25% for Q4 2021, changed N/A from a year ago — trailing twelve months through Sep 2022 was 92.0% (down 28481.0% YoY), and the annual figure for FY2021 was 24.76%, down 63486.0%.
  • FCF Margin for Q4 2021 was 39.25% at Atea Pharmaceuticals, down from 68.89% in the prior quarter.
  • Over the last five years, FCF Margin for AVIR hit a ceiling of 68.89% in Q3 2021 and a floor of 39.25% in Q4 2021.